Figure S1. The expression of NEAT1 was upregulated in LPS-induced DC maturation. (A) The expression of NEAT1 in DCs stimulated with the agonists lipoteichoic acid (TLR2), polyinosinic-polycytidylic acid (TLR3), and TLR7/8 (R848) for 24 h was detected by qRT-PCR. Data are expressed as mean ± SD; n = 3 biological replicates; ***p<0.001, ns, not significant, derived using Student's t-test. (B) DCs were stimulated with LPS (10 ng/ml, 200 ng/ml, or 1 µg/m). NEAT1 v1 expression was determined by qRT-PCR at different time points (0, 4, 8, 12, and 24 h). (C-D) DCs were treated with Lipofectamine or LPS for 12 h, and the expression levels of co-stimulators (CD80, CD86, and MHC II) were detected by flow cytometry. Data are expressed as mean ± SD; n = 3 biological replicates; ***p<0.001, derived using Student's t-test. (E) DCs were treated with Lipofectamine or LPS for 12 h, and the expression of NEAT1v2 was detected by qRT-PCR. Data are expressed as mean ± SD; n = 3 biological replicates; ***p<0.001, derived using Student's t-test.
. Knockdown of NEAT1 induces tolerogenic DCs. (A) qRT-PCR was used to detect the expression of NEAT1 after siRNA-mediated knockdown of NEAT1 in DCs. (B) The expression levels of co-stimulators (CD80, CD86, and MHC II) were detected by flow cytometry in DCs treated with NEAT1 siRNA (siNEAT1) or negative control (NC) for 12 h before treatment with LPS (200 ng/ml). Data are expressed as mean ± SD; n = 4 biological replicates; ***p<0.001, derived using Student's t-test. (C-D) The levels of IL-1β and IL-6 were analyzed by ELISA in DC supernatants. Data are expressed as mean ± SD; n = 3 biological replicates; ***p<0.001, ****p<0.0001 derived using Student's t-test. Figure S3 . NEAT1 regulates the expression of NLRP3 inflammasome by competing for miR-3076-3p. (A) The altered miRNA levels were selectively confirmed by qRT-PCR in the knockdown of NEAT1. Data are expressed as mean ± SD; n = 3 biological replicates; **p<0.01, ***p<0.001, derived using Student's t-test. (B) DCs were treated with miR-3076-3p inhibitor or miR-3076-3p mimic for 12 h, and the expression of NEAT1v2 was detected by qRT-PCR. Data are expressed as mean ± SD; n = 3 biological replicates; ***p<0.001, derived using Student's t-test. (C-G) DCs were transfected with miR-3076-3p mimic, miR-3076 inhibitor, or NC. Relative mRNA expression of caspase-1 (C) and ASC (D) was detected by qRT-PCR. The protein levels of NLRP3 (E), caspase-1 (F), and ASC (G) were detected by western blotting. Data are expressed as mean ± SD; n = 3 biological replicates; **p<0.01, ***p<0.001, ****p<0.0001, derived using Student's t-test. (H-L) DCs transfected with siNEAT1, DCs overexpressing NEAT1 (OE NEAT1), DCs treated with siNEAT1+miR-3076-3p inhibitor or OE NEAT1+miR-3076-3p mimic, and negative control DCs. Relative mRNA expression of caspase-1 (H) and ASC (I) was detected by qRT-PCR. The protein levels of NLRP3 (J), caspase-1 (K), and ASC (L) were detected by western blotting. Data are expressed as mean ± SD; n = 3 biological replicates; **p<0.01, ***p<0.001, ns, not significant, derived using Student's t-test. Figure S4 . NEAT1 induces tol-DCs via miR-3076-3p/NLRP3 axis. (A -B) Western blotting was performed to detect the expression of NEAT1 after pcDNA-NLRP3 overexpression in DCs. Data are expressed as mean ± SD; n = 3 biological replicates; **p<0.01, derived using Student's t-test.
(C-D) DCs were treated with siNEAT1 or pcDNA-NLRP3, the control protein GAPDH was detected by western blot. Data are expressed as mean ± SD; n = 3 biological replicates; ns not significant, derived using Student's t-test. (E) The expression levels of co-stimulators (CD80, CD86, and MHC II) were detected by flow cytometry in DCs treated with siNEAT1, siNEAT1+pcDNA-NLRP3, or siNEAT1+pcDNA-NLRP3 in the presence of a neutralizing monoclonal antibody specific for IL-1β. Figure S5 . NEAT1 is regulated by the transcription factor E2F1. (A) The expression of E2F1 mRNA was detected by qRT-PCR in DCs treated with E2F1 siRNA, DCs overexpressing E2F1, or NC. Data are expressed as mean ± SD; n = 3 biological replicates; **p<0.01, ***p<0.001, ns, not significant, derived using Student's t-test. (B-C) The levels of the E2F1 protein were assessed by western blotting in DCs treated with E2F1 siRNA, DCs overexpressing E2F1, or NC. Data are expressed as mean ± SD; n = 3 biological replicates; ***p<0.001, ns, not significant, derived using Student's t-test. (D) CpG island distribution in the promoter of NEAT1. Horizontal axis denotes the genome sequence of NEAT1. Vertical blue stripes indicate CpG islands. (E) DCs were transfected with siE2F1 or NC for 12 h before undergoing stimulation with LPS. Methylation status of the CpG island was assessed by bisulfite sequencing in immature DCs (iDCs), LPS-DCs, NC, and siE2F1 DCs. Each row represents a single clone. (F) DCs were stimulated with an inhibitor of DNA methyltransferase (5-aza-2'-deoxycytidine) used at different concentrations (0.5 µM, 0.05 µM, 0.01 µM, or 0.005 µM) for 12 h before undergoing stimulation with LPS. The expression of NEAT1 was detected by qRT-PCR. Data are expressed as mean ± SD; n = 3 biological replicates; ***p<0.001, ns, not significant, derived using Student's t-test. Figure S6 . Expression of the components of the NLRP3 inflammasome in EAM mice subjected to infusion with NEAT1-knockdown DCs. (A) Hearts harvested from the PBS-injected group and the group transfected with NC-DCs were stained with hematoxylin and eosin (the PBS group was shown in Figure 5H ). Scale bars correspond to 100 µm. (B) Assessment of hematoxylin and eosin staining by grading. Data are expressed as mean ± SD; n = 5 biological replicates; ns, not significant, derived using Student's t-test. (C-E) Immunohistochemical labeling for NLRP3 (C), caspase-1 (D), and ASC (E) in hearts harvested from normal, PBS-treated, and siNEAT1-treated groups. Scale bars correspond to 50 µm. 
